Lan Yi serves as a Clinical Biomarker Lead for Alzheimer’s Disease at GSK. Prior experience includes roles as a postdoctoral researcher and research scientist at Rutgers Cancer Institute of New Jersey and at the University of Medicine and Dentistry of New Jersey, Rutgers University. This background reflects a strong foundation in clinical research and biomarker development within the field of cancer and neurodegenerative diseases.
This person is not in any teams
This person is not in any offices